Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Brand-name drug prices rising at slower pace, lower amounts: AP Analysis

      Brand-name drug prices rising at slower pace, lower amounts: AP Analysis

      Medical Dialogues Bureau29 Aug 2019 3:32 PM IST
      After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug prices provided by health...
      FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

      FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

      Medical Dialogues Bureau29 Aug 2019 9:35 AM IST
      The U.S. Food and Drug Administration said on Wednesday it had identified 63 cases of worsening liver function in certain patients taking hepatitis C...
      Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

      Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources

      Medical Dialogues Bureau29 Aug 2019 9:25 AM IST
      OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company...
      Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

      Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

      Medical Dialogues Bureau28 Aug 2019 5:04 PM IST
      New Delhi: In light of concerns raised in various forums, the Drugs Technical Advisory Board (DTAB) has recently recommended for finalization of the...
      Revised drug law to pave way for cheap Indian generic medicines in China: Report

      Revised drug law to pave way for cheap Indian generic medicines in China: Report

      Medical Dialogues Bureau28 Aug 2019 9:45 AM IST
      India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the USD 57 billion trade deficit in...
      Ipca Labs gets 3 USFDA observations for Silvassa unit

      Ipca Labs gets 3 USFDA observations for Silvassa unit

      Medical Dialogues Bureau28 Aug 2019 9:30 AM IST
      In a regulatory filing to BSE, Ipca Laboratories said the USFDA had conducted the inspection of its formulations manufacturing unit situated at...
      AstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga

      AstraZeneca gets USFDA fast track status for development of diabetes drug Farxiga

      Medical Dialogues Bureau28 Aug 2019 9:15 AM IST
      Farxiga, one of AstraZeneca Plc's top 10 drugs by sales, is part of the SGLT2-inhibitor class of antidiabetics that cause the kidneys to expel blood...
      CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details

      CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details

      Medical Dialogues Bureau27 Aug 2019 3:50 PM IST
      The said FDC of centchroman and ethinyloestradiol is a regular oral contraceptive pill sold under various brand names of contraceptive like Mala N,...
      Lupin inks commercial pact with Creso Pharma for cannaQIX

      Lupin inks commercial pact with Creso Pharma for cannaQIX

      Medical Dialogues Bureau27 Aug 2019 10:00 AM IST
      As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe,...
      SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

      SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

      Medical Dialogues Bureau27 Aug 2019 9:45 AM IST
      Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a...
      Boehringer Ingelheim to restructure executive board

      Boehringer Ingelheim to restructure executive board

      Medical Dialogues Bureau27 Aug 2019 9:30 AM IST
      Allan Hillgrove, head of pharmaceuticals and biopharma and a company veteran of 37 years, will retire at the end of the year and will be replaced by...
      JnJ directed to pay USD 572 million for opioid addiction crisis

      JnJ directed to pay USD 572 million for opioid addiction crisis

      Medical Dialogues Bureau27 Aug 2019 9:20 AM IST
      Norman (US): An Oklahoma judge on Monday found Johnson and Johnson(JnJ) and its subsidiaries helped fuel the state's opioid drug crisis and ordered...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok